In summary, our findings explore the generation and functions of tumor-induced CD8+ Treg cells that suppress the anti-tumor immunity alone or synergistically with CD4+ Treg cells indicating that targeting only CD4+ Treg is not sufficient to circumvent tumor immune evasion. The gene discussed is CD8A; the disease is neoplasm.